Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
Identifieur interne : 000134 ( 2020/Analysis ); précédent : 000133; suivant : 000135Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
Auteurs : Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]Source :
- Rheumatology international [ 1437-160X ] ; 2020.
Abstract
Amyloidosis secondary to juvenile idiopathic arthritis is a known complication of poorly controlled systemic juvenile idiopathic arthritis (SJIA), occurring in 1-2% of the patients. The IL-6 inhibitor tocilizumab is effective in controlling systemic signs and symptoms of sJIA and may be of therapeutic benefit in secondary amyloidosis. Herein, we report the clinical timeline of a 10-year boy with sJIA and secondary amyloidosis, who showed a sustained improvement of systemic symptoms and a reduction in proteinuria with tocilizumab. Compared to the data on adult patients affected with the secondary amyloidosis, there are very few reports on therapeutic options for the children affected with SJIA and secondary amyloidosis in the paediatric population. While doing a systematic literature search for writing this review, we could only retrieve nine case reports and one case series of the children affected with SJIA and secondary amyloidosis, including five cases which were treated with tocilizumab. We also looked into the clinical and biochemical response to various agents that have been used in the previous cases, including tocilizumab. The available literature and the present case report suggest that tocilizumab may be considered as a safe and effective option to treat SJIA-related secondary amyloidosis.
DOI: 10.1007/s00296-019-04363-z
PubMed: 31273457
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000348
- to stream PubMed, to step Curation: 000348
- to stream PubMed, to step Checkpoint: 000069
- to stream Ncbi, to step Merge: 002118
- to stream Ncbi, to step Curation: 002118
- to stream Ncbi, to step Checkpoint: 002118
- to stream Main, to step Merge: 000134
- to stream Main, to step Curation: 000134
- to stream Main, to step Exploration: 000134
- to stream 2020, to step Extraction: 000134
Links to Exploration step
pubmed:31273457Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.</title><author><name sortKey="Gupta, Ayush" sort="Gupta, Ayush" uniqKey="Gupta A" first="Ayush" last="Gupta">Ayush Gupta</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Bagri, Narendra Kumar" sort="Bagri, Narendra Kumar" uniqKey="Bagri N" first="Narendra Kumar" last="Bagri">Narendra Kumar Bagri</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. drnarendrabagri@yahoo.co.in.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Division of Rheumatology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Tripathy, Saroj Kumar" sort="Tripathy, Saroj Kumar" uniqKey="Tripathy S" first="Saroj Kumar" last="Tripathy">Saroj Kumar Tripathy</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Barwad, Adarsh" sort="Barwad, Adarsh" uniqKey="Barwad A" first="Adarsh" last="Barwad">Adarsh Barwad</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pathology, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Phulware, Ravi Hari" sort="Phulware, Ravi Hari" uniqKey="Phulware R" first="Ravi Hari" last="Phulware">Ravi Hari Phulware</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pathology, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Hari, Pankaj" sort="Hari, Pankaj" uniqKey="Hari P" first="Pankaj" last="Hari">Pankaj Hari</name><affiliation wicri:level="1"><nlm:affiliation>Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:31273457</idno><idno type="pmid">31273457</idno><idno type="doi">10.1007/s00296-019-04363-z</idno><idno type="wicri:Area/PubMed/Corpus">000348</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000348</idno><idno type="wicri:Area/PubMed/Curation">000348</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000348</idno><idno type="wicri:Area/PubMed/Checkpoint">000069</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000069</idno><idno type="wicri:Area/Ncbi/Merge">002118</idno><idno type="wicri:Area/Ncbi/Curation">002118</idno><idno type="wicri:Area/Ncbi/Checkpoint">002118</idno><idno type="wicri:Area/Main/Merge">000134</idno><idno type="wicri:Area/Main/Curation">000134</idno><idno type="wicri:Area/Main/Exploration">000134</idno><idno type="wicri:Area/2020/Extraction">000134</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.</title><author><name sortKey="Gupta, Ayush" sort="Gupta, Ayush" uniqKey="Gupta A" first="Ayush" last="Gupta">Ayush Gupta</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Bagri, Narendra Kumar" sort="Bagri, Narendra Kumar" uniqKey="Bagri N" first="Narendra Kumar" last="Bagri">Narendra Kumar Bagri</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. drnarendrabagri@yahoo.co.in.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Division of Rheumatology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Tripathy, Saroj Kumar" sort="Tripathy, Saroj Kumar" uniqKey="Tripathy S" first="Saroj Kumar" last="Tripathy">Saroj Kumar Tripathy</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Barwad, Adarsh" sort="Barwad, Adarsh" uniqKey="Barwad A" first="Adarsh" last="Barwad">Adarsh Barwad</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pathology, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Phulware, Ravi Hari" sort="Phulware, Ravi Hari" uniqKey="Phulware R" first="Ravi Hari" last="Phulware">Ravi Hari Phulware</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pathology, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Hari, Pankaj" sort="Hari, Pankaj" uniqKey="Hari P" first="Pankaj" last="Hari">Pankaj Hari</name><affiliation wicri:level="1"><nlm:affiliation>Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author></analytic><series><title level="j">Rheumatology international</title><idno type="eISSN">1437-160X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Amyloidosis secondary to juvenile idiopathic arthritis is a known complication of poorly controlled systemic juvenile idiopathic arthritis (SJIA), occurring in 1-2% of the patients. The IL-6 inhibitor tocilizumab is effective in controlling systemic signs and symptoms of sJIA and may be of therapeutic benefit in secondary amyloidosis. Herein, we report the clinical timeline of a 10-year boy with sJIA and secondary amyloidosis, who showed a sustained improvement of systemic symptoms and a reduction in proteinuria with tocilizumab. Compared to the data on adult patients affected with the secondary amyloidosis, there are very few reports on therapeutic options for the children affected with SJIA and secondary amyloidosis in the paediatric population. While doing a systematic literature search for writing this review, we could only retrieve nine case reports and one case series of the children affected with SJIA and secondary amyloidosis, including five cases which were treated with tocilizumab. We also looked into the clinical and biochemical response to various agents that have been used in the previous cases, including tocilizumab. The available literature and the present case report suggest that tocilizumab may be considered as a safe and effective option to treat SJIA-related secondary amyloidosis.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><country name="Inde"><noRegion><name sortKey="Gupta, Ayush" sort="Gupta, Ayush" uniqKey="Gupta A" first="Ayush" last="Gupta">Ayush Gupta</name></noRegion><name sortKey="Bagri, Narendra Kumar" sort="Bagri, Narendra Kumar" uniqKey="Bagri N" first="Narendra Kumar" last="Bagri">Narendra Kumar Bagri</name><name sortKey="Barwad, Adarsh" sort="Barwad, Adarsh" uniqKey="Barwad A" first="Adarsh" last="Barwad">Adarsh Barwad</name><name sortKey="Hari, Pankaj" sort="Hari, Pankaj" uniqKey="Hari P" first="Pankaj" last="Hari">Pankaj Hari</name><name sortKey="Phulware, Ravi Hari" sort="Phulware, Ravi Hari" uniqKey="Phulware R" first="Ravi Hari" last="Phulware">Ravi Hari Phulware</name><name sortKey="Tripathy, Saroj Kumar" sort="Tripathy, Saroj Kumar" uniqKey="Tripathy S" first="Saroj Kumar" last="Tripathy">Saroj Kumar Tripathy</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000134 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000134 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:31273457
|texte= Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:31273457" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a TocilizumabV1
| This area was generated with Dilib version V0.6.34. |  |